Search results

Technologies 12

View all

• LactoRING for a Healthy Vaginal Microbiome
  LactoRING is a novel slow-release vaginal ring designed to ensure continuous replenishment of Lactobacillus, promoting a healthy vaginal microbiome for a longer duration. The slow-release mechanism and targeted delivery to the vaginal environment will enhance the efficacy and convenience of treatment, thereby providing a comprehensive approach to vaginal dysbiosis management.
• Placental Accreta Spectrum Diagnostic
  Placenta accreta spectrum (PAS) is a condition where the placenta attaches too deeply into the uterine wall, causing severe bleeding and complications for the mother. PAS occurs in 1 in 300 to 500 deliveries — a 10-fold increase in the past 50 years. However, more than 50% of cases are not detected before delivery. To...
• Fistula Repair: Minimally-Invasive Repair of Obstetric Fistula
  Obstetric fistula is a devastating condition characterized by an abnormal connection between the female genital tract and the bladder or rectum. It affects more than two million women in Africa and Asia and leads to constant leakage of blood, urine, and stool, causing pain, infection, social ostracization, and physical isolation. Current treatment through reconstructive surgery...
• TORCH: Discovering Ovarian Torsion Biomarkers through Proteomics
  Ovarian torsion (OT) is a serious medical condition where an ovary twists around the tissue that supports it, which can cut off blood supply to the ovary and sometimes the fallopian tube, causing severe pain. If blood flow is not quickly restored, the ovary might need to be surgically removed. Current diagnostic methods are often...
• BioControl: Safe and Reversible Birth Control
  The long-term impact of birth control remains largely unknown, and as our knowledge of traditional methods evolves, so must our innovations to uncover safe, effective, and non-hormonal options. By way of novel compounds that slow sperm function, this technology is offering a new form of male and vaginal contraceptive. Our early tests show promising results,...
• FERTIVA: Enhanced Ovarian Tissue Engraftment for Fertility
  Nearly 80% of women who survive cancer go on to struggle with fertility. Our team is developing an innovative approach using ovarian tissue cryopreservation: freezing and storing ovarian tissue to preserve fertility potential. By combining patient-derived cells and innovative techniques, we are accelerating tissue engraftment, boosting pregnancy rates, and preserving vital ovarian function. Our multidisciplinary...